WASHINGTON – AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal, Clinical Chemistry, has increased to 7.9 in the 2014 Thomson Reuters Journal Citation Reports. This increase places Clinical Chemistry in the top 3% of all academic journals and reflects the significant influence of the research it publishes on laboratory medicine and patient care.
Laboratory medicine is essential to high quality patient care and quality of life—without it, patients might receive the wrong diagnosis, inappropriate treatment, or no treatment at all if an illness isn’t accurately detected. As the leading international journal of laboratory medicine, Clinical Chemistry has always been committed to driving progress in laboratory testing by highlighting innovative research at the forefront of the field. Every year, Clinical Chemistry publishes 2,000 pages of peer-reviewed papers that advance clinical testing and are selected based on the novelty of their findings as well as the rigorousness of the scientific work they detail. These papers cover subjects ranging from molecular diagnostics and women’s health to laboratory management.
Clinical Chemistry’s rising impact factor is a testament to the superior quality of the research it publishes, as is the journal’s 2014 immediacy index of 2.0, which places it in the top 2.8% of all academic journals. A journal’s impact factor is determined by the number of times articles published in the journal are cited over a two year period, while the immediacy index is determined by the journal citations in a single calendar year. These rankings are a measure of a journal’s influence, as well as the relevance and timeliness of the work it publishes. Both are determined by Thomson Reuters, a recognized authority for evaluating the usefulness of a journal.
“With Clinical Chemistry, AACC strives to provide lab professionals with the vital scientific information they need to discover new adaptive solutions to challenging patient health problems,” said AACC CEO Janet B. Kreizman. “We at AACC are excited to see Clinical Chemistry’s impact factor climb, which is a sign that, as the journal grows, it continues to succeed in its mission to provide an international forum for the publication of original articles that address the complexity of the evolving healthcare landscape.”
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.
Clinical Chemistry is the leading international journal of clinical laboratory science, providing 2,000 pages per year of peer-reviewed papers that advance the science of the field. With an impact factor of 7.9, Clinical Chemistry covers everything from molecular diagnostics to laboratory management.